Effectiveness, Safety, and Health-Related Outcomes of NUEDEXTA® in Nursing Home Patients With Pseudobulbar Affect (PBA)

Stopped The study was terminated prematurely because of difficulty with recruiting.

Conditions

• Pseudobulbar Affect (Involuntary Laughing and/or Crying)

Interventions

• DRUG: NUEDEXTA®

Sponsor

Avanir Pharmaceuticals